196 related articles for article (PubMed ID: 25407936)
1. Wnt5A promotes an adaptive, senescent-like stress response, while continuing to drive invasion in melanoma cells.
Webster MR; Xu M; Kinzler KA; Kaur A; Appleton J; O'Connell MP; Marchbank K; Valiga A; Dang VM; Perego M; Zhang G; Slipicevic A; Keeney F; Lehrmann E; Wood W; Becker KG; Kossenkov AV; Frederick DT; Flaherty KT; Xu X; Herlyn M; Murphy ME; Weeraratna AT
Pigment Cell Melanoma Res; 2015 Mar; 28(2):184-95. PubMed ID: 25407936
[TBL] [Abstract][Full Text] [Related]
2. WNT5A expression increases during melanoma progression and correlates with outcome.
Da Forno PD; Pringle JH; Hutchinson P; Osborn J; Huang Q; Potter L; Hancox RA; Fletcher A; Saldanha GS
Clin Cancer Res; 2008 Sep; 14(18):5825-32. PubMed ID: 18794093
[TBL] [Abstract][Full Text] [Related]
3. A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion.
Jenei V; Sherwood V; Howlin J; Linnskog R; Säfholm A; Axelsson L; Andersson T
Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19473-8. PubMed ID: 19901340
[TBL] [Abstract][Full Text] [Related]
4. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.
Bachmann IM; Straume O; Puntervoll HE; Kalvenes MB; Akslen LA
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8606-14. PubMed ID: 16361544
[TBL] [Abstract][Full Text] [Related]
5. Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration.
Schwartz AL; Malgor R; Dickerson E; Weeraratna AT; Slominski A; Wortsman J; Harii N; Kohn AD; Moon RT; Schwartz FL; Goetz DJ; Kohn LD; McCall KD
Clin Cancer Res; 2009 Jun; 15(12):4114-22. PubMed ID: 19470740
[TBL] [Abstract][Full Text] [Related]
6. [Preparation of the recombinant lentiviral expression vector targeting human Wnt5a gene and its inhibitory effect on melanoma cell invasion].
Zhao Y; Miao Y; Chen X; Wang L; Lu F; Liao W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):462-5. PubMed ID: 24796738
[TBL] [Abstract][Full Text] [Related]
7. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.
Ekström EJ; Bergenfelz C; von Bülow V; Serifler F; Carlemalm E; Jönsson G; Andersson T; Leandersson K
Mol Cancer; 2014 Apr; 13():88. PubMed ID: 24766647
[TBL] [Abstract][Full Text] [Related]
8. Heparan sulfate proteoglycan modulation of Wnt5A signal transduction in metastatic melanoma cells.
O'Connell MP; Fiori JL; Kershner EK; Frank BP; Indig FE; Taub DD; Hoek KS; Weeraratna AT
J Biol Chem; 2009 Oct; 284(42):28704-12. PubMed ID: 19696445
[TBL] [Abstract][Full Text] [Related]
9. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma.
Weeraratna AT; Jiang Y; Hostetter G; Rosenblatt K; Duray P; Bittner M; Trent JM
Cancer Cell; 2002 Apr; 1(3):279-88. PubMed ID: 12086864
[TBL] [Abstract][Full Text] [Related]
10. Silencing of CerS6 increases the invasion and glycolysis of melanoma WM35, WM451 and SK28 cell lines via increased GLUT1-induced downregulation of WNT5A.
Tang Y; Cao K; Wang Q; Chen J; Liu R; Wang S; Zhou J; Xie H
Oncol Rep; 2016 May; 35(5):2907-15. PubMed ID: 26934938
[TBL] [Abstract][Full Text] [Related]
11. Assaying Wnt5A-mediated invasion in melanoma cells.
O'Connell MP; French AD; Leotlela PD; Weeraratna AT
Methods Mol Biol; 2008; 468():243-53. PubMed ID: 19099260
[TBL] [Abstract][Full Text] [Related]
12. Wnt5A activates the calpain-mediated cleavage of filamin A.
O'Connell MP; Fiori JL; Baugher KM; Indig FE; French AD; Camilli TC; Frank BP; Earley R; Hoek KS; Hasskamp JH; Elias EG; Taub DD; Bernier M; Weeraratna AT
J Invest Dermatol; 2009 Jul; 129(7):1782-9. PubMed ID: 19177143
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of a WNT5A-IL-6 positive feedback loop in melanoma cells: Dual interference of this loop more effectively impairs melanoma cell invasion.
Linnskog R; Mohapatra P; Moradi F; Prasad CP; Andersson T
Oncotarget; 2016 Jun; 7(25):37790-37802. PubMed ID: 27191257
[TBL] [Abstract][Full Text] [Related]
14. Wnt ligand expression in malignant melanoma: pilot study indicating correlation with histopathological features.
Pham K; Milovanovic T; Barr RJ; Truong T; Holcombe RF
Mol Pathol; 2003 Oct; 56(5):280-5. PubMed ID: 14514922
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of the expression of Wnt5a promotes the proliferation of pancreatic cancer cells in vitro and in a nude mouse model.
Bo H; Gao L; Chen Y; Zhang J; Zhu M
Mol Med Rep; 2016 Feb; 13(2):1163-71. PubMed ID: 26648282
[TBL] [Abstract][Full Text] [Related]
16. Expression of Wnt5a and its downstream effector beta-catenin in uveal melanoma.
Zuidervaart W; Pavey S; van Nieuwpoort FA; Packer L; Out C; Maat W; Jager MJ; Gruis NA; Hayward NK
Melanoma Res; 2007 Dec; 17(6):380-6. PubMed ID: 17992121
[TBL] [Abstract][Full Text] [Related]
17. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition.
Dissanayake SK; Wade M; Johnson CE; O'Connell MP; Leotlela PD; French AD; Shah KV; Hewitt KJ; Rosenthal DT; Indig FE; Jiang Y; Nickoloff BJ; Taub DD; Trent JM; Moon RT; Bittner M; Weeraratna AT
J Biol Chem; 2007 Jun; 282(23):17259-71. PubMed ID: 17426020
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 drives melanoma cell motility through p38α-MAPK-dependent up-regulation of WNT5A expression.
Linnskog R; Jönsson G; Axelsson L; Prasad CP; Andersson T
Mol Oncol; 2014 Dec; 8(8):1365-78. PubMed ID: 24954857
[TBL] [Abstract][Full Text] [Related]
19. Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway.
Hung TH; Hsu SC; Cheng CY; Choo KB; Tseng CP; Chen TC; Lan YW; Huang TT; Lai HC; Chen CM; Chong KY
Oncotarget; 2014 Dec; 5(23):12273-90. PubMed ID: 25401518
[TBL] [Abstract][Full Text] [Related]
20. Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice.
Bakker ER; Das AM; Helvensteijn W; Franken PF; Swagemakers S; van der Valk MA; ten Hagen TL; Kuipers EJ; van Veelen W; Smits R
Carcinogenesis; 2013 Nov; 34(11):2629-38. PubMed ID: 23764752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
